Literature DB >> 17605053

Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome.

M F Seidel1, A Belda Domene, H Vetter.   

Abstract

The symptoms of Lyme borreliosis are similar to those of a variety of autoimmune musculoskeletal diseases. Persistence of complaints is frequently interpreted as unsuccessful antibiotic treatment of Borrelia-associated infections. However, such refractory cases are rare, and re-evaluation of differential diagnoses helps to avoid the substantial risk of long-term antibiotic therapy. In this study, we analyzed patients who presented to our rheumatology unit with previous suspected or diagnosed Lyme borreliosis. Eighty-six patients from a 3.5-year period were evaluated. The mean age of patients was 49.2 +/- 17.2 years; 60% (n = 52) reported a tick bite and 33% (n = 28) an erythema. Forty-seven percent (n = 39) had positive enzyme-linked immunoassay results and Western blots (Mikrogen, Martinsried, Germany). All but 12 patients had already received antibiotic treatment previously. Nine percent (n = 8) had ongoing or recent Lyme borreliosis. Twenty-nine percent (n = 25) showed clinical symptoms and radiographic changes compatible with degenerative disorders of the cervical and/or lumbar spine. These patients were significantly older when compared to the other patients (59.3 +/- 13.7 years vs 46.1 +/- 17.2 years, p = 0.001). Seventeen percent (n = 16) had arthropathies related to psoriasis or rheumatoid arthritis. Twelve percent (n = 10) were positive for the HLA B27 antigen. Other diseases were less frequent. Six patients (7%) could not be diagnosed conclusively, and four of these patients had negative Borrelia immunoassay results. In conclusion, Borrelia-associated diseases were rare in this study. Differential diagnoses helped to initiate a successful disease-specific therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17605053     DOI: 10.1007/s10096-007-0342-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  38 in total

1.  Investigation of venereal, transplacental, and contact transmission of the Lyme disease spirochete, Borrelia burgdorferi, in Syrian hamsters.

Authors:  J E Woodrum; J H Oliver
Journal:  J Parasitol       Date:  1999-06       Impact factor: 1.276

2.  Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; G Lehnert; R Lobentanzer; B Wilske
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

3.  Proposed classification criteria of psoriatic arthritis. A preliminary study in 260 patients.

Authors:  B Fournié; L Crognier; C Arnaud; L Zabraniecki; V Lascaux-Lefebvre; V Marc; E Ginesty; V Andrieu; C Dromer; A Fournié
Journal:  Rev Rhum Engl Ed       Date:  1999-10

4.  Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

Authors:  D Hassler; L Zöller; M Haude; H D Hufnagel; F Heinrich; H G Sonntag
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

5.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

Authors:  D M Gross; T Forsthuber; M Tary-Lehmann; C Etling; K Ito; Z A Nagy; J A Field; A C Steere; B T Huber
Journal:  Science       Date:  1998-07-31       Impact factor: 47.728

6.  The overdiagnosis of Lyme disease in children residing in an endemic area.

Authors:  C D Rose; P T Fawcett; K M Gibney; R A Doughty
Journal:  Clin Pediatr (Phila)       Date:  1994-11       Impact factor: 1.168

7.  Demonstration of Borrelia burgdorferi DNA in urine samples from healthy humans whose sera contain B. burgdorferi-specific antibodies.

Authors:  H Karch; H I Huppertz; M Böhme; H Schmidt; D Wiebecke; A Schwarzkopf
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis.

Authors:  N L Weiss; V A Sadock; L H Sigal; M Phillips; P F Merryman; S B Abramson
Journal:  Lupus       Date:  1995-04       Impact factor: 2.911

9.  "Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia.

Authors:  V M Hsu; S J Patella; L H Sigal
Journal:  Arthritis Rheum       Date:  1993-11

10.  Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status.

Authors:  Richard S Kalish; Jonathan A Wood; William Golde; Robert Bernard; Larry E Davis; Roger C Grimson; Patricia K Coyle; Benjamin J Luft
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

View more
  5 in total

Review 1.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 2.  Chronic Lyme disease: a review.

Authors:  Adriana Marques
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

3.  Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans.

Authors:  John N Aucott; Lauren A Crowder; Victoria Yedlin; Kathleen B Kortte
Journal:  Dermatol Res Pract       Date:  2012-10-24

Review 4.  Treatment of Lyme borreliosis.

Authors:  Hermann J Girschick; Henner Morbach; Dennis Tappe
Journal:  Arthritis Res Ther       Date:  2009-12-17       Impact factor: 5.156

5.  Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.

Authors:  Ruben Magni; Benjamin H Espina; Ketul Shah; Benjamin Lepene; Christine Mayuga; Temple A Douglas; Virginia Espina; Sally Rucker; Ross Dunlap; Emanuel F Iii Petricoin; Mary Frekko Kilavos; Donald M Poretz; Gilbert R Irwin; Samuel M Shor; Lance A Liotta; Alessandra Luchini
Journal:  J Transl Med       Date:  2015-11-04       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.